Evidence map›Paper›PMID 28257475›Full record

ArticlePloS one2017

Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation.

Ian Ross, Carlos Mejia, Johanna Melendez, Philip A Chan, Amy C Nunn, William Powderly, Katherine Goodenberger, Jingxia Liu, Kenneth H Mayer, Rupa R Patel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ian RossDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Carlos MejiaDivision of Infectious Diseases, Roosevelt Hospital, Guatemala City, Guatemala.
Johanna MelendezDivision of Infectious Diseases, Roosevelt Hospital, Guatemala City, Guatemala.
Philip A ChanDivision of Infectious Diseases, Brown University, Providence, Rhode Island, United States of America.
Amy C NunnDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island, United States of America.
William PowderlyDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Katherine GoodenbergerDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Jingxia LiuDivision of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Kenneth H MayerDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Rupa R PatelDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Washington University in St. Louis · USBrown University · USRoosevelt Hospital · GTHarvard University · US

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Molecular Epidemiology of HIV Transmission NetworksK23AI096923 · NIAID · MIRIAM HOSPITAL · PI CHAN, PHILIP ANDREW · 2011 to 2015
$650k
NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NIAID NIH HHS K23 AI096923NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

introductionHIV continues to be a major health concern with approximately 2.1 million new infections occurring worldwide in 2015. In Central America, Guatemala had the highest incident number of HIV infections (3,700) in 2015. Antiretroviral pre-exposure prophylaxis (PrEP) was recently recommended by the World Health Organization (WHO) as an efficacious intervention to prevent HIV transmission. PrEP implementation efforts are underway in Guatemala and success will require providers that are knowledgeable and willing to prescribe PrEP. We sought to explore current PrEP awareness and prescribing attitudes among Guatemalan physicians in order to inform future PrEP implementation efforts.

methodsWe conducted a cross-sectional survey of adult internal medicine physicians at the main teaching hospital in Guatemala City in March 2015. The survey included demographics, medical specialty, years of HIV patient care, PrEP awareness, willingness to prescribe PrEP, previous experience with post-exposure prophylaxis, and concerns about PrEP. The primary outcome was willingness to prescribe PrEP, which was assessed using a 5-point Likert scale for different at-risk population scenarios. Univariate and multivariate logistic regression was performed to identify predictors for willingness to prescribe PrEP.

resultsEighty-seven physicians completed the survey; 66% were male, 64% were internal medicine residency trainees, and 10% were infectious disease (ID) specialists. Sixty-nine percent of physicians were PrEP aware, of which 9% had previously prescribed PrEP. Most (87%) of respondents were willing to prescribe PrEP to men who have sex with men (MSM), sex workers, injection drug users, or HIV-uninfected persons having known HIV-positive sexual partners. Concerns regarding PrEP included development of resistance (92%), risk compensation (90%), and cost (64%). Univariate logistic regression showed that younger age, being a resident trainee, and being a non-ID specialist were significant predictors for willingness to prescribe PrEP. In multivariate logistic regression, being a non-ID specialist was a significant predictor.

conclusionsGuatemalan physicians at an urban public hospital were PrEP aware and willing to prescribe, but few have actually done so yet. Future education programs should address the concerns identified, including the low potential for the development of antiretroviral resistance. These findings can aid PrEP implementation efforts in Guatemala.

Indexed as

Attitude of Health PersonnelHealth Knowledge, Attitudes, PracticeAdultAnti-HIV AgentsCross-Sectional StudiesFemaleGuatemalaHIV InfectionsHumansLogistic ModelsMaleMiddle AgedPhysiciansPractice Patterns, Physicians'Pre-Exposure ProphylaxisSurveys and QuestionnairesAnti-HIV Agents

Identifiers

PMID28257475
PMCPMC5336255
OpenAlexW2593735682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.